Published On: Wed, Oct 19th, 2016

Broker Changes For HCP, Inc. (NYSE:HCP)


Recently stock market analysts have updated their consensus ratings on shares of HCP, Inc. (NYSE:HCP).

Most recent broker ratings

10/04/2016 – HCP, Inc. was upgraded to “neutral” by analysts at Bank of America Merrill Lynch. They now have a USD 38.5 price target on the stock.

08/25/2016 – BTIG Research began new coverage on HCP, Inc. giving the company a “neutral” rating.

08/24/2016 – HCP, Inc. had its “neutral” rating reiterated by analysts at Citigroup. They now have a USD 38 price target on the stock.

08/23/2016 – HCP, Inc. had its “neutral” rating reiterated by analysts at UBS. They now have a USD 38 price target on the stock.

08/10/2016 – HCP, Inc. had its “neutral” rating reiterated by analysts at Mizuho. They now have a USD 37 price target on the stock.

07/26/2016 – Raymond James began new coverage on HCP, Inc. giving the company a “underperform” rating.

07/08/2016 – HCP, Inc. was upgraded to “neutral” by analysts at Goldman Sachs. They now have a USD 36 price target on the stock.

06/22/2016 – HCP, Inc. was downgraded to “underweight” by analysts at Morgan Stanley. They now have a USD 32 price target on the stock.

05/10/2016 – HCP, Inc. was upgraded to “hold” by analysts at Jefferies. They now have a USD 32 price target on the stock.

03/10/2016 – HCP, Inc. had its “underweight” rating reiterated by analysts at Barclays. They now have a USD 33 price target on the stock.

02/11/2016 – HCP, Inc. was downgraded to “sell” by analysts at Stifel Nicolaus. They now have a USD 23 price target on the stock.

02/10/2016 – HCP, Inc. was downgraded to “long-term buy” by analysts at Hilliard Lyons.

02/10/2016 – HCP, Inc. had its “hold” rating reiterated by analysts at Evercore ISI. They now have a USD 31 price target on the stock.

02/10/2016 – HCP, Inc. had its “underperform” rating reiterated by analysts at BMO Capital Markets. They now have a USD 27 price target on the stock.

01/04/2016 – HCP, Inc. was downgraded to “hold” by analysts at Argus.

HCP, Inc. has a 50 day moving average of 37.80 and a 200 day moving average of 36.29. The stock’s market capitalization is 17.16B, it has a 52-week low of 25.11 and a 52-week high of 40.43.

The share price of the company (NYSE:HCP) was up +1.02% during the last trading session, with a high of 37.09 and the volume of HCP, Inc. shares traded was 2473668.

HCP, Inc. is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities. Its Life science properties contain laboratory and office space for biotechnology, medical device and pharmaceutical companies, scientific research institutions, government agencies and other organizations. Its Medical office buildings contain physicians’ offices and examination rooms, and may include pharmacies, hospital ancillary service space and outpatient services. As of December 31, 2016, it had interests in and managed 15 hospitals, 61 care homes in the United Kingdom and five post-acute/skilled nursing facilities.